Globus Historical Income Statement
GMED Stock | USD 82.63 0.69 0.84% |
Historical analysis of Globus Medical income statement accounts such as Total Revenue of 1.6 B or Gross Profit of 533.4 M can show how well Globus Medical performed in making a profits. Evaluating Globus Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Globus Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Globus Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Globus Medical is a good buy for the upcoming year.
Globus |
About Globus Income Statement Analysis
Globus Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Globus Medical shareholders. The income statement also shows Globus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Globus Medical Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Globus Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Globus Medical minus its cost of goods sold. It is profit before Globus Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Globus Medical. It is also known as Globus Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Globus Medical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Globus Medical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Globus Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 1.6 B, whereas EBIT is forecasted to decline to about 163.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 718.9M | 759.1M | 1.0B | 533.4M | Total Revenue | 958.1M | 1.0B | 1.6B | 1.6B |
Globus Medical income statement Correlations
Click cells to compare fundamentals
Globus Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Globus Medical income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 58.0M | 62.9M | 69.9M | 68.3M | 144.7M | 152.0M | |
Interest Expense | 17.4M | 14.0M | 9.3M | 14.2M | 20.1M | 21.1M | |
Total Revenue | 785.4M | 789.0M | 958.1M | 1.0B | 1.6B | 1.6B | |
Gross Profit | 605.4M | 571.6M | 718.9M | 759.1M | 1.0B | 533.4M | |
Other Operating Expenses | 608.6M | 673.6M | 763.2M | 786.6M | 1.4B | 1.5B | |
Operating Income | 172.0M | 111.4M | 172.0M | 228.0M | 133.1M | 153.7M | |
Ebit | 172.0M | 115.5M | 180.4M | 236.3M | 165.4M | 163.4M | |
Research Development | 60.1M | 84.5M | 97.3M | 73.0M | 124.0M | 130.2M | |
Ebitda | 230.0M | 178.3M | 250.3M | 304.5M | 310.1M | 211.4M | |
Cost Of Revenue | 180.0M | 217.5M | 239.2M | 263.7M | 548.2M | 575.6M | |
Total Operating Expenses | 428.6M | 456.1M | 524.0M | 522.9M | 887.2M | 931.5M | |
Income Before Tax | 189.9M | 125.9M | 180.4M | 243.0M | 165.4M | 162.4M | |
Total Other Income Expense Net | 18.0M | 14.5M | 8.5M | 15.1M | 32.3M | 33.9M | |
Net Income | 155.2M | 102.3M | 149.2M | 190.2M | 122.9M | 117.3M | |
Income Tax Expense | 34.7M | 23.6M | 31.2M | 52.9M | 42.5M | 44.9M | |
Net Income Applicable To Common Shares | 155.2M | 102.3M | 149.2M | 190.2M | 218.7M | 120.8M | |
Net Income From Continuing Ops | 155.2M | 102.3M | 149.2M | 190.2M | 122.9M | 131.6M | |
Tax Provision | 34.7M | 23.6M | 31.2M | 52.9M | 42.5M | 34.9M | |
Net Interest Income | 17.4M | 14.0M | 9.3M | 14.2M | 20.1M | 13.5M | |
Reconciled Depreciation | 52.7M | 62.9M | 69.9M | 68.3M | 144.7M | 75.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 42.231 | Earnings Share 0.62 | Revenue Per Share 18.217 | Quarterly Revenue Growth 0.631 | Return On Assets 0.0473 |
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.